Hydrix Ltd
Company Profile
Business description
Hydrix Ltd provides product design and development consulting services to clients in the medical and defense technology sectors, marketing remote cardiac monitoring technologies and managing a portfolio of venture investments in early-stage medtech companies. Its segments are Hydrix Services provides multidisciplinary product design and development consulting across medtech, cardiac health, defence, and industrial sectors, offering services from applied research through to certification management; Hydrix Medical focused on the distribution of disruptive cardiovascular technologies under exclusive licence agreements across Australia and the Asia Pacific region; and Hydrix Ventures selectively invests in high-potential medtech clients of Hydrix Services.
Contact
30-32 Compark Circuit
Mulgrave
MelbourneVIC3170
AUST: +61 395508100
Sector
Technology
Stock type
Sensitive
Industry
Scientific & Technical Instruments
Fiscal Year End
Employees
60
Stocks News & Analysis
stocks
Our view after Coles’ shares plunge
stocks
Cheap ASX share remains overlooked by the market
stocks
Microsoft earnings: Azure accelerates, but investment returns remain the test
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,977.20 | 48.20 | -0.53% |
| CAC 40 | 7,996.77 | 27.35 | 0.34% |
| DAX 40 | 25,885.61 | 67.40 | 0.26% |
| Dow JONES (US) | 51,770.31 | 572.25 | -1.09% |
| FTSE 100 | 10,742.06 | 12.28 | 0.11% |
| HKSE | 23,393.32 | 98.90 | 0.42% |
| NASDAQ | 25,437.00 | 747.73 | -2.86% |
| Nikkei 225 | 63,081.86 | 208.25 | -0.33% |
| NZX 50 Index | 13,698.63 | 98.37 | -0.71% |
| S&P 500 | 7,580.07 | 140.32 | -1.82% |
| S&P/ASX 200 | 8,856.50 | 51.60 | -0.58% |
| SSE Composite Index | 3,638.03 | 39.01 | 1.08% |